251 related articles for article (PubMed ID: 9848523)
1. Daidzein conjugates are more bioavailable than genistein conjugates in rats.
King RA
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1496S-1499S. PubMed ID: 9848523
[TBL] [Abstract][Full Text] [Related]
2. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans.
King RA; Bursill DB
Am J Clin Nutr; 1998 May; 67(5):867-72. PubMed ID: 9583843
[TBL] [Abstract][Full Text] [Related]
3. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women.
Setchell KD; Faughnan MS; Avades T; Zimmer-Nechemias L; Brown NM; Wolfe BE; Brashear WT; Desai P; Oldfield MF; Botting NP; Cassidy A
Am J Clin Nutr; 2003 Feb; 77(2):411-9. PubMed ID: 12540402
[TBL] [Abstract][Full Text] [Related]
4. Dietary fructooligosaccharides modify intestinal bioavailability of a single dose of genistein and daidzein and affect their urinary excretion and kinetics in blood of rats.
Uehara M; Ohta A; Sakai K; Suzuki K; Watanabe S; Adlercreutz H
J Nutr; 2001 Mar; 131(3):787-95. PubMed ID: 11238760
[TBL] [Abstract][Full Text] [Related]
5. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake.
Arai Y; Uehara M; Sato Y; Kimira M; Eboshida A; Adlercreutz H; Watanabe S
J Epidemiol; 2000 Mar; 10(2):127-35. PubMed ID: 10778038
[TBL] [Abstract][Full Text] [Related]
6. Daily intake and urinary excretion of genistein and daidzein by infants fed soy- or dairy-based infant formulas.
Irvine CH; Shand N; Fitzpatrick MG; Alexander SL
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1462S-1465S. PubMed ID: 9848517
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako).
Watanabe S; Yamaguchi M; Sobue T; Takahashi T; Miura T; Arai Y; Mazur W; Wähälä K; Adlercreutz H
J Nutr; 1998 Oct; 128(10):1710-5. PubMed ID: 9772140
[TBL] [Abstract][Full Text] [Related]
8. Urinary pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein.
Shelnutt SR; Cimino CO; Wiggins PA; Badger TM
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):413-9. PubMed ID: 10794486
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage.
Shelnutt SR; Cimino CO; Wiggins PA; Ronis MJ; Badger TM
Am J Clin Nutr; 2002 Sep; 76(3):588-94. PubMed ID: 12198004
[TBL] [Abstract][Full Text] [Related]
10. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.
Védrine N; Mathey J; Morand C; Brandolini M; Davicco MJ; Guy L; Rémésy C; Coxam V; Manach C
Eur J Clin Nutr; 2006 Sep; 60(9):1039-45. PubMed ID: 16482068
[TBL] [Abstract][Full Text] [Related]
11. Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans.
Lu LJ; Anderson KE
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1500S-1504S. PubMed ID: 9848524
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women.
Anupongsanugool E; Teekachunhatean S; Rojanasthien N; Pongsatha S; Sangdee C
BMC Clin Pharmacol; 2005 Mar; 5():2. PubMed ID: 15743537
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.
Setchell KD; Brown NM; Desai P; Zimmer-Nechemias L; Wolfe BE; Brashear WT; Kirschner AS; Cassidy A; Heubi JE
J Nutr; 2001 Apr; 131(4 Suppl):1362S-75S. PubMed ID: 11285356
[TBL] [Abstract][Full Text] [Related]
14. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women.
Xu X; Wang HJ; Murphy PA; Cook L; Hendrich S
J Nutr; 1994 Jun; 124(6):825-32. PubMed ID: 8207540
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men.
Busby MG; Jeffcoat AR; Bloedon LT; Koch MA; Black T; Dix KJ; Heizer WD; Thomas BF; Hill JM; Crowell JA; Zeisel SH
Am J Clin Nutr; 2002 Jan; 75(1):126-36. PubMed ID: 11756070
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production.
Vergne S; Titier K; Bernard V; Asselineau J; Durand M; Lamothe V; Potier M; Perez P; Demotes-Mainard J; Chantre P; Moore N; Bennetau-Pelissero C; Sauvant P
J Pharm Biomed Anal; 2007 Mar; 43(4):1488-94. PubMed ID: 17110073
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes.
Setchell KD; Brown NM; Desai PB; Zimmer-Nechimias L; Wolfe B; Jakate AS; Creutzinger V; Heubi JE
J Nutr; 2003 Apr; 133(4):1027-35. PubMed ID: 12672914
[TBL] [Abstract][Full Text] [Related]
18. Transdermal absorption of phytoestrogens.
Vänttinen K; Moravcova J
Pharmazie; 2001 Sep; 56(9):711-7. PubMed ID: 11593991
[TBL] [Abstract][Full Text] [Related]
19. Altered time course of urinary daidzein and genistein excretion during chronic soya diet in healthy male subjects.
Lu LJ; Grady JJ; Marshall MV; Ramanujam VM; Anderson KE
Nutr Cancer; 1995; 24(3):311-23. PubMed ID: 8610050
[TBL] [Abstract][Full Text] [Related]
20. Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity.
Zhang Y; Wang GJ; Song TT; Murphy PA; Hendrich S
J Nutr; 1999 May; 129(5):957-62. PubMed ID: 10222386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]